Reine Allan (CIK 1714023) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-05-22). Recent activity: Buy PRME (125,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-22 | Prime Medicine, Inc. (PRME) | Chief Executive Officer | Buy | 125,000 | $147,500 |
Source: SEC Form 4 filings · as of 2025-05-22